What do we offer?
Clinical trials in rare diseases are not just smaller versions of large (conventional) trials and have specific requirements. Therefore, tailormade services are needed to tackle practical, logistical and strategic challenges.
PSR, as a full service Orphan Drug CRO, provides biopharmaceutical companies with a wide array of unique services that allow end-to-end solutions spanning the whole Orphan drug development cycle. We aim to support our clients with an integrated approach from regulatory strategy through to conducting the necessary clinical studies in all phases.